EMA to hold public hearing on quinolone and fluoroquinolone antibiotic safety

The European Medicines Agency (EMA) has  announced that its Pharmacovigilance Risk Assessment Committee will hold a public hearing on quinolone and fluoroquinolone antibiotics, as part of an ongoing safety review into the drugs.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research